Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Narayana A; Kelly P; Golfinos J; Parker E; Johnson G; Knopp E; Zagzag D; Fischer I; Raza S; Medabalmi P

doi:10.3171/2008.4.17492

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Identifier:nobleid.org/w1/20260526/0B1DF1AB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0B1DF1AB.svg?ark=w1%2F20260526%2F0B1DF1AB)](https://nobleid.org/work/w1/20260526/0B1DF1AB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Identifier:nobleid.org/w1/20260526/0B1DF1AB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0B1DF1AB.svg?ark=w1%2F20260526%2F0B1DF1AB)](https://nobleid.org/work/w1/20260526/0B1DF1AB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work